GENNEX LABORATORIES
Back to Balance Sheet
|
GENNEX LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹17 Cr | ₹13 Cr | ₹16 Cr | ₹0.00 Cr | ₹0.17 Cr |
What is the latest Total Non-Current Liabilities ratio of GENNEX LABORATORIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹17 Cr |
| Mar2024 | ₹13 Cr |
| Mar2023 | ₹16 Cr |
| Mar2022 | ₹0.00 Cr |
| Mar2021 | ₹0.17 Cr |
How is Total Non-Current Liabilities of GENNEX LABORATORIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹17 Cr | 28.73 | |
| Mar2024 | ₹13 Cr | -19.60 | |
| Mar2023 | ₹16 Cr | 538,266.67 | |
| Mar2022 | ₹0.00 Cr | -98.21 | |
| Mar2021 | ₹0.17 Cr | - | |
Compare Total Non-Current Liabilities of peers of GENNEX LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GENNEX LABORATORIES | ₹233.4 Cr | -0.3% | -17.3% | -16.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,539.0 Cr | -3.2% | -7.8% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 1% | 0.9% | 67.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,251.0 Cr | -1.8% | -4.8% | 32.2% | Stock Analytics | |
| CIPLA | ₹105,290.0 Cr | -3.1% | -6.5% | -12.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,752.6 Cr | -1.7% | 3.1% | -3.5% | Stock Analytics | |
GENNEX LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GENNEX LABORATORIES | -0.3% |
-17.3% |
-16.8% |
| SENSEX | 0.8% |
-4.8% |
-10.5% |
You may also like the below Video Courses